BACKGROUND: The aim of this study was to examine the potential usefulness of a mammaglobin multigene reverse transcription-PCR (RT-PCR) assay and a mammaglobin sandwich ELISA as diagnostic tools in breast cancer. METHODS: We studied peripheral blood samples from 147 untreated Senegalese women with biopsy-confirmed breast cancer and gathered patient information regarding demographic, and clinical staging of disease. The samples were tested for mammaglobin and three breast cancer-associated gene transcripts by a multigene real-time RT-PCR assay and for serum mammaglobin protein by a sandwich ELISA assay. RESULTS: In 77% of the breast cancer blood samples, a positive signal was obtained in the multigene RT-PCR assay detecting mammaglobin and three complementary transcribed genes. Fifty samples from healthy female donors tested negative. Significant correlations were found between mammaglobin protein in serum, presence of mammaglobin mRNA-expressing cells in blood, stage of disease, and tumor size. Circulating mammaglobin protein was detected in 68% of the breast cancer sera, and was increased in 38% in comparison with a mixed control population. The RT-PCR assay and the ELISA for mammaglobin produced a combined sensitivity of 84% and specificity of 97%. CONCLUSION: The ELISA and RT-PCR for mammaglobin and mammaglobin-producing cells could be valuable tools for diagnosis and prognosis of breast cancer.
BACKGROUND: The aim of this study was to examine the potential usefulness of a mammaglobin multigene reverse transcription-PCR (RT-PCR) assay and a mammaglobin sandwich ELISA as diagnostic tools in breast cancer. METHODS: We studied peripheral blood samples from 147 untreated Senegalese women with biopsy-confirmed breast cancer and gathered patient information regarding demographic, and clinical staging of disease. The samples were tested for mammaglobin and three breast cancer-associated gene transcripts by a multigene real-time RT-PCR assay and for serum mammaglobin protein by a sandwich ELISA assay. RESULTS: In 77% of the breast cancer blood samples, a positive signal was obtained in the multigene RT-PCR assay detecting mammaglobin and three complementary transcribed genes. Fifty samples from healthy female donors tested negative. Significant correlations were found between mammaglobin protein in serum, presence of mammaglobin mRNA-expressing cells in blood, stage of disease, and tumor size. Circulating mammaglobin protein was detected in 68% of the breast cancer sera, and was increased in 38% in comparison with a mixed control population. The RT-PCR assay and the ELISA for mammaglobin produced a combined sensitivity of 84% and specificity of 97%. CONCLUSION: The ELISA and RT-PCR for mammaglobin and mammaglobin-producing cells could be valuable tools for diagnosis and prognosis of breast cancer.
Authors: J Klug; H M Beier; A Bernard; B S Chilton; T P Fleming; R I Lehrer; L Miele; N Pattabiraman; G Singh Journal: Ann N Y Acad Sci Date: 2000 Impact factor: 5.691
Authors: M Ooka; Y Tamaki; I Sakita; Y Fujiwara; H Yamamoto; Y Miyake; M Sekimoto; M Ohue; Y Sugita; Y Miyoshi; N Ikeda; S Noguchi; M Monden Journal: Breast Cancer Res Treat Date: 2001-05 Impact factor: 4.872
Authors: K Grünewald; M Haun; M Urbanek; M Fiegl; E Müller-Holzner; E Gunsilius; M Dünser; C Marth; G Gastl Journal: Lab Invest Date: 2000-07 Impact factor: 5.662
Authors: R L Houghton; D C Dillon; D A Molesh; B K Zehentner; J Xu; J Jiang; C Schmidt; A Frudakis; E Repasky; A Maltez Filho; M Nolasco; R Badaro; X Zhang; P C Roche; D H Persing; S G Reed Journal: Mol Diagn Date: 2001-06
Authors: B Suchy; F Austrup; G Driesel; C Eder; I Kusiak; P Uciechowski; H J Grill; M Giesing Journal: Cancer Lett Date: 2000-10-01 Impact factor: 8.679
Authors: Barbara K Zehentner; Heather Secrist; Dawn C Hayes; Xinqun Zhang; Richard C Ostenson; Steven Loop; Gary Goodman; Raymond L Houghton; David H Persing Journal: Mol Diagn Ther Date: 2006 Impact factor: 4.074
Authors: Julie M Galvis-Jiménez; Hernando Curtidor; Manuel A Patarroyo; Pedro Monterrey; Sandra R Ramírez-Clavijo Journal: Cancer Biol Ther Date: 2013-01-28 Impact factor: 4.742
Authors: Kaidi Mikhitarian; Renee Hebert Martin; Megan Baker Ruppel; William E Gillanders; Rana Hoda; Del H Schutte; Kathi Callahan; Michael Mitas; David J Cole Journal: BMC Cancer Date: 2008-02-20 Impact factor: 4.430
Authors: I H Benoy; H Elst; M Philips; H Wuyts; P Van Dam; S Scharpé; E Van Marck; P B Vermeulen; L Y Dirix Journal: Br J Cancer Date: 2006-03-13 Impact factor: 7.640